[Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?].
Schmidt
S
S
Max-Planck-Institut für Psychiatrie, Abteilung Neuroimmunologie, Martinsried, München.
Hohlfeld
R
R
D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome
Aktuelle Therapie der multiplen Sklerose: Gibt es Indikationen für intravenöse Immunglobuline?